Accession Number: | 0001209191-20-058237 |
Date: | 2020-11-11 |
Issuer: | FIVE PRIME THERAPEUTICS, INC. (FPRX) |
Original Submission Date: |
COLLINS HELEN LOUISE
111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-11-11 | M | 22,000 | a | $0.00 | 86,156 | direct | ||
COMMON STOCK | 2020-11-11 | F | 11,039 | d | $18.00 | 75,117 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
PERFORMANCE-BASED RESTRICTED COMMON STOCK | 0.0 | 2020-11-11 | deemed execution date | M | 22,000 (d) | common stock 22,000 | $0.00 | 22,000 | direct |
ID | footnote |
---|---|
f1 | represents shares of performance-based restricted common stock granted to the reporting person on june 24, 2019. these shares vested on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of five prime therapeutics, inc. (the "company") was greater than or equal to $12.95. |
f2 | the shares subject to this grant vest upon achievement of certain performance conditions, as further described in the other footnotes to this report. |
f3 | represents 50% of the shares subject to this award, which shares vested on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of the company was greater than or equal to $12.95. |
f4 | the remaining shares subject to this award will vest on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of the company is greater than or equal to $19.43, subject to the reporting person's continued service to the company through such date; provided that such shares shall automatically expire and be forfeited if such shares have not vested by december 31, 2021. |